Sideroflexin 4 Antikörper (N-Term)
Kurzübersicht für Sideroflexin 4 Antikörper (N-Term) (ABIN7184502)
Target
Alle Sideroflexin 4 (SFXN4) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Human
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from N-terminal of Human SFXN4.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB:1:500-1:3000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Sideroflexin 4 (SFXN4)
-
Andere Bezeichnung
- SFXN4
-
Hintergrund
-
Background: Potential iron transporter By similarity.
Zheng H., DNA Seq. 14:369-373(2003).
Deloukas P., Nature 429:375-381(2004).
The MGC Project Team, Genome Res. 14:2121-2127(2004).Aliases: SFXN4 antibody, BCRM1 antibody, Sideroflexin-4 antibody, Breast cancer resistance marker 1 antibody
-
UniProt
- Q6P4A7
-
Pathways
- Transition Metal Ion Homeostasis
Target
-